Affymetrix (AFFX) 11.45 $AFFX
Strength Seen in Curis (CRIS): Stock Moves 9.2% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 8:25AM CST
Curis (CRIS) was a big mover last session, with shares rising over 9% on the day.
CRIS: 3.23 (+0.25), AFFX: 11.45 (+0.02)
EPIRUS Biopharmaceuticals (EPRS) Jumps: Stock Up 18.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 7:51AM CST
EPIRUS Biopharmaceuticals (EPRS) was a big mover last session, as the company saw its shares rise nearly 19% on the day.
EPRS: 7.67 (+0.67), AFFX: 11.45 (+0.02)
CorMedix (CRMD) Shows Strength: Stock Moves Up 5.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 7:51AM CST
CorMedix, Inc. (CRMD) was a big mover last session, as the company saw its shares rise almost 6% on the day.
CRMD: 3.27 (+0.02), AFFX: 11.45 (+0.02)
Regional Banks Are The Way To Go - Cramer's Lightning Round (2/11/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Feb 12, 5:05AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, February 11. Bullish Calls: HomeAway (NASDAQ: AWAY ): "The stock market is saying it is overvalued but I think don't give up on CEO Brian." ...
ACHC: 63.20 (-0.45), KMI: 41.97 (+0.21), CY: 14.76 (+0.01), AWAY: 29.68 (+0.11), BBT: 38.28 (-0.04), PWR: 28.76 (-0.10), AMGN: 153.48 (+0.30), BA: 149.73 (+1.64), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), CELG: 115.88 (+0.16), VIA: 69.08 (+1.02), ETP: 60.17 (+0.96), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), REGN: 402.40 (+0.66)
'Mad Money' Lightning Round: Buy, Buy, Buy Boeing Below $140
at The Street - Thu Feb 12, 5:00AM CST
Cramer says don't give up on HomeAway, Quanta Services is too risk but Acadia Healthcare is terrific.
ACHC: 63.20 (-0.45), KMI: 41.97 (+0.21), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), AWAY: 29.68 (+0.11), BBT: 38.28 (-0.04), PWR: 28.76 (-0.10), AMGN: 153.48 (+0.30), KEY: 14.11 (-0.08), BA: 149.73 (+1.64), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), CELG: 115.88 (+0.16), ETP: 60.17 (+0.96), STI: 41.57 (+0.01), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), REGN: 402.40 (+0.66)
Jim Cramer's 'Mad Money' Recap: Get Ready to Profit on Europe-Induced Weakness
at The Street - Wed Feb 11, 7:14PM CST
Lots of investors are worried about Europe, Cramer says, but you don't have to be.
KMI: 41.97 (+0.21), ACHC: 63.20 (-0.45), FLEX: 12.05 (-0.09), GE: 25.15 (+0.26), BBT: 38.28 (-0.04), AWAY: 29.68 (+0.11), XOM: 93.37 (+1.00), KEY: 14.11 (-0.08), INTC: 34.36 (+0.23), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), PEP: 99.13 (-1.14), AEP: 57.83 (-0.15), ETP: 60.17 (+0.96), CMG: 674.89 (+4.60), QLYS: 47.95 (+1.46), GOOGL: 551.16 (+5.15), MSFT: 43.87 (+0.78), HSIC: 143.18 (+0.72), AAPL: 127.08 (+0.62), REGN: 402.40 (+0.66), CSCO: 29.43 (-0.03), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), PWR: 28.76 (-0.10), FB: 75.74 (-0.49), PFE: 34.64 (-0.23), HAL: 44.19 (+1.42), AMGN: 153.48 (+0.30), BAC: 16.61 (-0.06), BMY: 60.04 (+0.56), BA: 149.73 (+1.64), HPQ: 38.56 (+0.19), RAD: 8.34 (+0.25), CELG: 115.88 (+0.16), ZTS: 45.46 (-0.33), UA: 73.76 (-0.19), AA: 15.81 (+0.16), GILD: 101.90 (+1.10), STI: 41.57 (+0.01), GM: 37.62 (-0.40), AGIO: 118.55 (+0.11), CRL: 73.61 (-0.33), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), CL: 70.08 (+0.23)
Genomic Health Loss Narrower than Expected, Revenues Lag - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 9:06AM CST
Genomic Health (GHDX) delivered mixed financial numbers in fourth-quarter 2014 with bottom-line beat but revenue miss.
BMRN: 100.76 (+1.98), OPHT: 51.11 (+0.12), GHDX: 31.12 (+0.28), AFFX: 11.45 (+0.02)
Strength Seen in Anthera (ANTH): Stock Soars 25% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 8:25AM CST
Anthera (ANTH) was a big mover last session, with shares surging 25% on the day.
ANTH: 3.84 (+0.06), AFFX: 11.45 (+0.02)
Exelixis (EXEL) Catches Eye: Stock Adds 15.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 7:51AM CST
Exelixis, Inc. (EXEL) was a big mover last session, as the company saw its shares rise almost 16% on the day.
AFFX: 11.45 (+0.02), EXEL: 2.48 (+0.20)
Acorda Therapeutics (ACOR) Tumbles: Stock Goes Down 9.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 7:50AM CST
Acorda Therapeutics' shares fell nearly 10% continuing the recent downtrend
ACOR: 36.14 (-0.51), AFFX: 11.45 (+0.02)
Affymetrix Up 38.9% Since SmarTrend Uptrend Call (AFFX)
Comtex SmarTrend(R) - Tue Feb 10, 4:50PM CST
SmarTrend identified an Uptrend for Affymetrix (NASDAQ:AFFX) on October 30th, 2014 at $8.10. In approximately 3 months, Affymetrix has returned 38.89% as of today's recent price of $11.25.
AFFX: 11.45 (+0.02)
MannKind (MNKD) Looks Good: Stock Adds 7.8% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 8:25AM CST
MannKind (MNKD) was a big mover last session, with shares rising nearly 8% on the day.
MNKD: 7.00 (+0.02), AFFX: 11.45 (+0.02)
Avalanche Biotechnologies (AAVL) Jumps: Stock Up 8.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 7:51AM CST
Avalanche Biotechnologies, Inc. (AAVL) was a big mover last session, as the company saw its shares rise almost 9% on the day.
AAVL: 36.29 (+0.01), AFFX: 11.45 (+0.02)
Pfenex (PFNX) Looks Good: Stock Adds 5.7% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 7:30AM CST
Pfenex Inc. (PFNX) was a big mover last session, as the company saw its shares rise roughly 6% on the day.
PFNX: 12.45 (+0.29), AFFX: 11.45 (+0.02)
Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
BEBE: 3.90 (+0.01), CHU: 16.90 (+0.04), ALK: 62.56 (-0.19), AFFX: 11.45 (+0.02), AEIS: 26.68 (-0.32)
Intercept Pharmaceuticals (ICPT) Jumps: Stock Adds 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:25AM CST
Intercept Pharmaceuticals (ICPT) was a big mover last session, with shares rising roughly 10% on the day.
ICPT: 209.12 (+7.12), AFFX: 11.45 (+0.02)
AstraZeneca Lags Q4 Earnings, to Boost Respiratory Portfolio - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:02AM CST
AstraZeneca (AZN) reported fourth-quarter 2014 core earnings of 76 cents per ADS that missed the Zacks Consensus Estimate by 8 cents.
ACT: 285.37 (+3.71), AZN: 69.96 (+0.20), BMY: 60.04 (+0.56), AFFX: 11.45 (+0.02)
Coherus Biosciences (CHRS) Jumps: Stock Moves Up 12.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 7:51AM CST
Coherus Biosciences, Inc. (CHRS) was a big mover last session, as the company saw its shares rise almost 13% on the day.
AFFX: 11.45 (+0.02), CHRS: 27.11 (-0.71)
Affymetrix to Webcast Presentation at the 2015 Leerink Global Healthcare Conference
Business Wire - Fri Feb 06, 5:00AM CST
Affymetrix, Inc. (Nasdaq:AFFX) today announced that it will webcast the Company's presentation at the Leerink Global Healthcare Conference in New York City on Wednesday February 11, 2015. The live webcast is scheduled to begin at 10:15 a.m. ET and will feature a corporate update by Frank Witney, president and chief executive officer.
AFFX: 11.45 (+0.02)
Affymetrix (AFFX) Earnings, Revenues Outshine Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 8:56AM CST
Affymetrix Inc. (AFFX) reported adjusted earnings per share (EPS) of 9 cents in the fourth quarter of 2014, which managed to beat the Zacks Consensus Estimate by a couple of cents
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), AFFX: 11.45 (+0.02), SURG: 4.44 (-0.02)
Strength Seen in Curis (CRIS): Stock Moves 9.2% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 8:25AM CST
Curis (CRIS) was a big mover last session, with shares rising over 9% on the day.
CRIS: 3.23 (+0.25), AFFX: 11.45 (+0.02)
EPIRUS Biopharmaceuticals (EPRS) Jumps: Stock Up 18.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 7:51AM CST
EPIRUS Biopharmaceuticals (EPRS) was a big mover last session, as the company saw its shares rise nearly 19% on the day.
EPRS: 7.67 (+0.67), AFFX: 11.45 (+0.02)
CorMedix (CRMD) Shows Strength: Stock Moves Up 5.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 7:51AM CST
CorMedix, Inc. (CRMD) was a big mover last session, as the company saw its shares rise almost 6% on the day.
CRMD: 3.27 (+0.02), AFFX: 11.45 (+0.02)
Regional Banks Are The Way To Go - Cramer's Lightning Round (2/11/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Feb 12, 5:05AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, February 11. Bullish Calls: HomeAway (NASDAQ: AWAY ): "The stock market is saying it is overvalued but I think don't give up on CEO Brian." ...
ACHC: 63.20 (-0.45), KMI: 41.97 (+0.21), CY: 14.76 (+0.01), AWAY: 29.68 (+0.11), BBT: 38.28 (-0.04), PWR: 28.76 (-0.10), AMGN: 153.48 (+0.30), BA: 149.73 (+1.64), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), CELG: 115.88 (+0.16), VIA: 69.08 (+1.02), ETP: 60.17 (+0.96), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), REGN: 402.40 (+0.66)
'Mad Money' Lightning Round: Buy, Buy, Buy Boeing Below $140
at The Street - Thu Feb 12, 5:00AM CST
Cramer says don't give up on HomeAway, Quanta Services is too risk but Acadia Healthcare is terrific.
ACHC: 63.20 (-0.45), KMI: 41.97 (+0.21), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), AWAY: 29.68 (+0.11), BBT: 38.28 (-0.04), PWR: 28.76 (-0.10), AMGN: 153.48 (+0.30), KEY: 14.11 (-0.08), BA: 149.73 (+1.64), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), CELG: 115.88 (+0.16), ETP: 60.17 (+0.96), STI: 41.57 (+0.01), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), REGN: 402.40 (+0.66)
Jim Cramer's 'Mad Money' Recap: Get Ready to Profit on Europe-Induced Weakness
at The Street - Wed Feb 11, 7:14PM CST
Lots of investors are worried about Europe, Cramer says, but you don't have to be.
KMI: 41.97 (+0.21), ACHC: 63.20 (-0.45), FLEX: 12.05 (-0.09), GE: 25.15 (+0.26), BBT: 38.28 (-0.04), AWAY: 29.68 (+0.11), XOM: 93.37 (+1.00), KEY: 14.11 (-0.08), INTC: 34.36 (+0.23), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), PEP: 99.13 (-1.14), AEP: 57.83 (-0.15), ETP: 60.17 (+0.96), CMG: 674.89 (+4.60), QLYS: 47.95 (+1.46), GOOGL: 551.16 (+5.15), MSFT: 43.87 (+0.78), HSIC: 143.18 (+0.72), AAPL: 127.08 (+0.62), REGN: 402.40 (+0.66), CSCO: 29.43 (-0.03), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), PWR: 28.76 (-0.10), FB: 75.74 (-0.49), PFE: 34.64 (-0.23), HAL: 44.19 (+1.42), AMGN: 153.48 (+0.30), BAC: 16.61 (-0.06), BMY: 60.04 (+0.56), BA: 149.73 (+1.64), HPQ: 38.56 (+0.19), RAD: 8.34 (+0.25), CELG: 115.88 (+0.16), ZTS: 45.46 (-0.33), UA: 73.76 (-0.19), AA: 15.81 (+0.16), GILD: 101.90 (+1.10), STI: 41.57 (+0.01), GM: 37.62 (-0.40), AGIO: 118.55 (+0.11), CRL: 73.61 (-0.33), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), CL: 70.08 (+0.23)
Genomic Health Loss Narrower than Expected, Revenues Lag - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 9:06AM CST
Genomic Health (GHDX) delivered mixed financial numbers in fourth-quarter 2014 with bottom-line beat but revenue miss.
BMRN: 100.76 (+1.98), OPHT: 51.11 (+0.12), GHDX: 31.12 (+0.28), AFFX: 11.45 (+0.02)
Strength Seen in Anthera (ANTH): Stock Soars 25% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 8:25AM CST
Anthera (ANTH) was a big mover last session, with shares surging 25% on the day.
ANTH: 3.84 (+0.06), AFFX: 11.45 (+0.02)
Exelixis (EXEL) Catches Eye: Stock Adds 15.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 7:51AM CST
Exelixis, Inc. (EXEL) was a big mover last session, as the company saw its shares rise almost 16% on the day.
AFFX: 11.45 (+0.02), EXEL: 2.48 (+0.20)
Acorda Therapeutics (ACOR) Tumbles: Stock Goes Down 9.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 7:50AM CST
Acorda Therapeutics' shares fell nearly 10% continuing the recent downtrend
ACOR: 36.14 (-0.51), AFFX: 11.45 (+0.02)
Affymetrix Up 38.9% Since SmarTrend Uptrend Call (AFFX)
Comtex SmarTrend(R) - Tue Feb 10, 4:50PM CST
SmarTrend identified an Uptrend for Affymetrix (NASDAQ:AFFX) on October 30th, 2014 at $8.10. In approximately 3 months, Affymetrix has returned 38.89% as of today's recent price of $11.25.
AFFX: 11.45 (+0.02)
MannKind (MNKD) Looks Good: Stock Adds 7.8% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 8:25AM CST
MannKind (MNKD) was a big mover last session, with shares rising nearly 8% on the day.
MNKD: 7.00 (+0.02), AFFX: 11.45 (+0.02)
Avalanche Biotechnologies (AAVL) Jumps: Stock Up 8.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 7:51AM CST
Avalanche Biotechnologies, Inc. (AAVL) was a big mover last session, as the company saw its shares rise almost 9% on the day.
AAVL: 36.29 (+0.01), AFFX: 11.45 (+0.02)
Pfenex (PFNX) Looks Good: Stock Adds 5.7% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 7:30AM CST
Pfenex Inc. (PFNX) was a big mover last session, as the company saw its shares rise roughly 6% on the day.
PFNX: 12.45 (+0.29), AFFX: 11.45 (+0.02)
Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
BEBE: 3.90 (+0.01), CHU: 16.90 (+0.04), ALK: 62.56 (-0.19), AFFX: 11.45 (+0.02), AEIS: 26.68 (-0.32)
Intercept Pharmaceuticals (ICPT) Jumps: Stock Adds 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:25AM CST
Intercept Pharmaceuticals (ICPT) was a big mover last session, with shares rising roughly 10% on the day.
ICPT: 209.12 (+7.12), AFFX: 11.45 (+0.02)
AstraZeneca Lags Q4 Earnings, to Boost Respiratory Portfolio - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:02AM CST
AstraZeneca (AZN) reported fourth-quarter 2014 core earnings of 76 cents per ADS that missed the Zacks Consensus Estimate by 8 cents.
ACT: 285.37 (+3.71), AZN: 69.96 (+0.20), BMY: 60.04 (+0.56), AFFX: 11.45 (+0.02)
Coherus Biosciences (CHRS) Jumps: Stock Moves Up 12.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 7:51AM CST
Coherus Biosciences, Inc. (CHRS) was a big mover last session, as the company saw its shares rise almost 13% on the day.
AFFX: 11.45 (+0.02), CHRS: 27.11 (-0.71)
Affymetrix to Webcast Presentation at the 2015 Leerink Global Healthcare Conference
Business Wire - Fri Feb 06, 5:00AM CST
Affymetrix, Inc. (Nasdaq:AFFX) today announced that it will webcast the Company's presentation at the Leerink Global Healthcare Conference in New York City on Wednesday February 11, 2015. The live webcast is scheduled to begin at 10:15 a.m. ET and will feature a corporate update by Frank Witney, president and chief executive officer.
AFFX: 11.45 (+0.02)
Affymetrix (AFFX) Earnings, Revenues Outshine Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 8:56AM CST
Affymetrix Inc. (AFFX) reported adjusted earnings per share (EPS) of 9 cents in the fourth quarter of 2014, which managed to beat the Zacks Consensus Estimate by a couple of cents
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), AFFX: 11.45 (+0.02), SURG: 4.44 (-0.02)
